Halogen-substituted pyrazol derivatives as pest-control agents
US-2015353500-A1 · Dec 10, 2015 · US
US10035773B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10035773-B2 |
| Application number | US-201615059759-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 3, 2016 |
| Priority date | Feb 1, 2012 |
| Publication date | Jul 31, 2018 |
| Grant date | Jul 31, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to novel 3,5-bis(fluoroalkyl)pyrazole-4-carboxylic acid derivatives and to a process for preparing 3,5-bis(fluoroalkyl)pyrazole-4-carboxylic acid derivatives and 3,5-bis(fluoroalkyl)pyrazoles.
Opening claim text (preview).
The invention claimed is: 1. A 3,5-Bis(fluoroalkyl)pyrazole of formula (Ia) or (Ib) in which R 1 is selected from H, C 1-12 -alkyl, C 3-8 -cycloalkyl, C 6-18 -aryl, C 7-19 -arylalkyl, C 7-19 -alkylaryl, CH 2 CN, CH 2 CX 3 , CH 2 COOH, or CH 2 COO—(C 1-12 )-alkyl; X is independently F, Cl, Br, or I; R 2 is difluoromethyl and R 3 is selected from C 1 -C 6 -haloalkyl groups, R 4 is selected from the group of COOH, (C═O)OR 5 , CN or (C═O)NR 5 R 6 , where R 5 and R 6 are each independently selected from the group consisting of C 1-12 -alkyl, C 3-8 -cycloalkyl, C 6-18 -aryl, C 7-19 -arylalkyl and C 7-19 -alkylaryl, or where R 5 and R 6 together with the nitrogen atom to which they are bonded may form a five- or six-membered ring. 2. The compound of formula (Ia) or (Ib) according to claim 1 , wherein R 1 is selected from H, methyl, CH 2 COOH, CH 2 COOR 5 , CH 2 CN, or CH 2 CX 3 : X is independently F or Cl; R 3 is selected from difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl or 1,1,1-trifluoroprop-2-yl; R 4 is selected from the group consisting of COOCH 3 , COOEt, COOC 3 H 7 , CN, CONMe 2 , and CONEt 2 . 3. The compound of formula (Ia) or (Ib) according to claim 1 , wherein R 1 is selected from H, CH 2 COOH, CH 2 COOMe, or CH 2 CN, R 3 is selected from the group consisting of trifluoromethyl, difluoromethyl, difluorochloromethyl, and pentafluoroethyl; R 4 is COOH. 4. The compound of formula (Ia) or (Ib) according to claim 1 , wherein R 1 =H; R 2 =CF 2 H and R 4 =COOH. 5. The compound of formula (Ia) or (Ib) according to claim 1 , wherein R 1 =tert-butyl, R 3 =CF 2 H and R 4 =CO 2 Et or COOH. 6. The compound of formula (Ia) or (Ib) according to claim 1 , wherein R 1 =H or tert-butyl, R 3 =CF 3 and R 4 =CO 2 Et or COOH. 7. A 3,5-Bis(fluoroalkyl)pyrazole of formula (Ia) or (Ib) in which R 1 is selected from H, C 1-12 -alkyl, C 3-8 -cycloalkyl, C 6-18 -aryl, C 7-19 -arylalkyl, C 7-19 -alkylaryl, CH 2 CN, or CH 2 CX 3 ; X is independently F, Cl, Br, or I; R 2 is difluoromethyl and R 3 is selected from C 1 -C 6 -haloalkyl groups, R 4 is selected from the group of COOH, (C═O)OR 5 , CN or (C═O)NR 5 R 6 , where R 5 and R 6 are each independently selected from the group consisting of C 1-12 -alkyl, C 3-8 -cycloalkyl, C 6-18 -aryl, C 7-19 -arylalkyl and C 7-19 -alkylaryl, or where R 5 and R 6 together with the nitrogen atom to which they are bonded may form a five- or six-membered ring. 8. The compound of formula (Ia) or (Ib) according to claim 7 , wherein R 4 is (C═O)OR 5 . 9. The compound of formula (Ia) or (Ib) according to claim 7 , wherein R 4 is COOH. 10. The compound of formula (Ia) or (Ib) according to claim 7 , wherein R 4 is CN. 11. The compound of formula (Ia) or (Ib) according to claim 7 , wherein R 4 is (C═O)NR 5 R 6 .
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics · CPC title
Drugs for dermatological disorders · CPC title
with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms · CPC title
the carbon skeleton being acyclic and unsaturated · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.